The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy
Authors:
- G. KorenGKG. Koren
- M. LishnerMLM. Lishner
Open Access
- 1 September 2007
- journal article
- review article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 92 (9) , 1230-1237
Abstract
Lymphoma is the fourth most frequent malignancy diagnosed during pregnancy, occurring in approximately 1:6000 of deliveries. Its occurrence may increase due to the current trend to postpone pregnancy until later in life and the suggested high incidence of AIDS-related non-Hodgkin9s lymphoma in developing countries. The relatively rare occurrence of pregnancy-associated lymphoma precludes the conduction of large, prospective studies to examine diagnostic, management and outcome issues. Chemotherapy and radiotherapy during the first trimester are associated with increased risk of congenital malformations and this risk diminishes as pregnancy advances. In the vast majority of cases, when lymphoma is diagnosed during the first trimester, treatment with a standard chemotherapy regimen, following pregnancy termination should be recommended. In the rare patients at low risk, such as those with stage 1 Hodgkin9s lymphoma or indolent non-Hodgkin9s lymphoma, therapy can be delayed until the end of the first trimester and of embryogenesis while keeping the patients under close observation. When lymphoma is diagnosed during the second and third trimesters, evidence exists suggesting that full-dose chemotherapy can be administered safely without apparent increased risk of severe adverse fetal outcome.Keywords
This publication has 42 references indexed in Scilit:
- Perfusion studies of glyburide transfer across the human placenta: Implications for fetal safetyAmerican Journal of Obstetrics and Gynecology, 2006
- Obstetric MRIJournal of Magnetic Resonance Imaging, 2006
- Cancer and pregnancy: Poena magna, not anymoreEuropean Journal of Cancer, 2006
- Changes in acquired immunodeficiency syndrome‐related non‐Hodgkin lymphoma in the era of highly active antiretroviral therapyCancer, 2005
- Long-term evaluation of cardiac function in children who received anthracyclines during pregnancyAnnals of Oncology, 2005
- AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral TherapyThe Oncologist, 2005
- The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled studyAlimentary Pharmacology & Therapeutics, 2005
- The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative studyBJOG: An International Journal of Obstetrics & Gynaecology, 2004
- Review: Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivorsInternational Journal of Radiation Biology, 1998
- Management of cancer during pregnancyArchives of internal medicine (1960), 1988